Department of Physics, Cancer Research Center, Ben-Gurion University (BGU), Beer-Sheva 84105, Israel.
Med Phys. 2010 Mar;37(3):1047-55. doi: 10.1118/1.3298013.
Colon cancer is a major public health problem due to its high disease rate and death toll worldwide. The use of FTIR microscopy in the field of cancer diagnosis has become attractive over the past 20 years. In the present study, the authors investigated the potential of FTIR microscopy to define spectral changes among normal, polyp, and cancer human colonic biopsied tissues.
A large database of FTIR microscopic spectra was compiled from 230 human colonic biopsies. The database was divided into five subgroups: Normal, cancerous tissues, and three stages of benign colonic polyps, namely, mild, moderate, and severe polyps, which are precursors of carcinoma. All biopsied tissue sections were classified concurrently by an expert pathologist. The authors applied the principal components analysis (PCA) model to reduce the dimension of the original data size to 13 principal components.
While PCA analysis shows only partial success in distinguishing among cancer, polyp, and the normal tissues, multivariate analysis (e.g., LDA) shows a promising distinction even within the polyp subgroups.
Good classification accuracy among normal, polyp, and cancer groups was achieved with a success rate of approximately 85%. These results strongly support the potential of developing FTIR microscopy as a simple, reagent-free tool for early detection of colon cancer and, in particular, for discriminating among the benign premalignant colonic polyps having increasing degrees of dysplasia severity (mild, moderate, and severe).
由于结肠癌在全球范围内的发病率和死亡率都很高,因此它是一个主要的公共卫生问题。过去 20 年来,FTIR 显微镜在癌症诊断领域的应用变得越来越有吸引力。在本研究中,作者研究了 FTIR 显微镜在定义正常、息肉和癌症人类结肠活检组织之间光谱变化方面的潜力。
从 230 个人类结肠活检组织中编制了一个大型的 FTIR 显微镜光谱数据库。该数据库分为五个子组:正常、癌变组织和三种良性结肠息肉阶段,即轻度、中度和重度息肉,它们是癌前病变。所有活检组织切片均由专家病理学家进行同时分类。作者应用主成分分析(PCA)模型将原始数据的维度降低到 13 个主成分。
尽管 PCA 分析仅在区分癌症、息肉和正常组织方面取得了部分成功,但多元分析(例如 LDA)甚至在息肉子组内也显示出了有希望的区分。
正常、息肉和癌症组之间的分类准确率达到了约 85%。这些结果有力地支持了将 FTIR 显微镜开发为一种简单、无试剂的工具用于早期检测结肠癌的潜力,特别是用于区分具有不同异型增生严重程度的良性癌前结肠息肉(轻度、中度和重度)。